Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Enterprise Value : 6.886M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 6.886M |
| September 24, 2026 | 6.931M |
| September 23, 2026 | 7.825M |
| September 22, 2026 | 8.228M |
| September 21, 2026 | 8.541M |
| September 18, 2026 | 8.675M |
| September 17, 2026 | 8.429M |
| September 16, 2026 | 7.960M |
| September 15, 2026 | 8.049M |
| September 14, 2026 | 7.960M |
| September 11, 2026 | 8.898M |
| September 10, 2026 | 9.144M |
| September 09, 2026 | 9.927M |
| September 08, 2026 | 9.882M |
| September 04, 2026 | 8.943M |
| September 03, 2026 | 8.764M |
| September 02, 2026 | 8.988M |
| September 01, 2026 | 7.87M |
| August 31, 2026 | 8.429M |
| August 28, 2026 | 8.854M |
| August 27, 2026 | 8.764M |
| August 26, 2026 | 8.988M |
| August 25, 2026 | 8.094M |
| August 24, 2026 | 7.781M |
| August 21, 2026 | 7.892M |
| Date | Value |
|---|---|
| August 20, 2026 | 8.094M |
| August 19, 2026 | 8.183M |
| August 18, 2026 | 7.937M |
| August 17, 2026 | 8.317M |
| August 14, 2026 | 8.183M |
| August 13, 2026 | 8.272M |
| August 12, 2026 | 8.764M |
| August 11, 2026 | 8.988M |
| August 10, 2026 | 8.809M |
| August 07, 2026 | 9.033M |
| August 06, 2026 | 9.077M |
| August 05, 2026 | 9.346M |
| August 04, 2026 | 9.659M |
| August 03, 2026 | 8.943M |
| July 31, 2026 | 6.931M |
| July 30, 2026 | 7.289M |
| July 29, 2026 | 7.691M |
| July 28, 2026 | 8.272M |
| July 27, 2026 | 8.228M |
| July 24, 2026 | 8.675M |
| July 23, 2026 | 8.630M |
| July 22, 2026 | 9.927M |
| July 21, 2026 | 10.60M |
| July 20, 2026 | 10.06M |
| July 17, 2026 | 10.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 628.60M |
| Amgen, Inc. | 267.45B |
| Anika Therapeutics, Inc. | 259.45M |
| BioCryst Pharmaceuticals, Inc. | 2.676B |
| Imunon, Inc. | 7.560M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.571M |
| Revenue (Quarterly) | 0.0209M |
| Total Expenses (Quarterly) | 2.592M |
| EPS Diluted (Quarterly) | -0.823 |
| Gross Profit Margin (Quarterly) | 47.37% |
| Profit Margin (Quarterly) | -12.30K% |
| Earnings Yield | -3.18K% |
| Normalized Earnings Yield | -947.72 |